Clinical Research

Clinical Research Experts

Andrew Mackie

Chief Business Officer, Executive Director
Directors & Officers


Mr. Andrew Mackie is Chief Business Officer, Executive Director of the Company, effective from 1 July 2015. Andrew brings with him over 25 years' industry experience in pre-clinical research, clinical development and business development, having held at number of senior R&D roles in pharmaceutical (Lilly, Novartis, Sanofi), service (MDS), and biotech companies (Antisoma). He joins Ergomed from Eli Lilly where he was working for the Business Development team. Prior to this, Andrew was Head of Life Sciences at IP Group. After ten years in R&D, Andrew joined the UK biotech sector in 1997 at Antisoma, the oncology specialist. He establish the clinical development department and transitioned new molecules into development and later managed Antisoma's strategic alliance with F Hoffman-La Roche and in-licensed new drug leads through partnerships and acquisitions.

Research Interest

Pre-clinical research, clinical development and business development

Global Experts from Swaziland

Global Experts in Subject

Share This Profile
Recommended Conferences
View more
Relevant Topics